• About Us
  • Who Are We
  • Work With Us
Friday, February 15, 2019
No Result
View All Result
NEWSLETTER
The Globe Post
39 °f
New York
44 ° Fri
46 ° Sat
40 ° Sun
41 ° Mon
  • National
  • World
  • Business
  • Interviews
  • Lifestyle
  • Democracy at Risk
    • Media Freedom
  • Opinion
    • Editorials
    • Columns
    • Book Reviews
    • Stage
  • Submit Op-ed
  • National
  • World
  • Business
  • Interviews
  • Lifestyle
  • Democracy at Risk
    • Media Freedom
  • Opinion
    • Editorials
    • Columns
    • Book Reviews
    • Stage
  • Submit Op-ed
No Result
View All Result
The Globe Post
No Result
View All Result
Home Lifestyle

America, We Have an Opioid Problem

Adam Chowdhury by Adam Chowdhury
February 12, 2018
in Lifestyle, Opinion
opioid addiction drug overdose
77
SHARES
Share on FacebookShare on Twitter

Every day, more than 90 Americans die from opioid or painkiller overdose. The abuse of opioids — including prescription painkillers, heroin, and synthetic opioids such as fentanyl — is a severe national crisis that affects public health, social and economic welfare.

The Centers for Disease Control and Prevention estimates the total economic burden of prescription opioid misuse in the United States is $78.5 billion a year, which includes the costs of healthcare, addiction treatment, and criminal justice involvement.

Working in the detox unit in West Philadelphia during one of my Psychiatry rotations, I met many patients who were prescribed opioids to cope with pain. Once their 30-day supply of “Perks” or “Oxy” ran out, many started using street drugs like heroin to satisfy their new addiction. As a result, they would end up in the hospital because of an overdose or withdrawal.

It makes me wonder, why are doctors so liberal when it comes to prescribing these addictive drugs? Furthermore, why haven’t prescription opioids been banned yet?

Like any good investigator, I decided to follow the money.

Senator Ron Wyden (D-OR) wrote a letter to Sylvia Burwell, the head of the Department of Health and Human Services (HHS). The letter was about the conflicts of interest at the Interagency Pain Research Coordinating Committee, convened as part of the Affordable Health Care Act to improve pain-related treatment strategies. Questions began to arise when members of the panel objected to federal suggestions that doctors reduce opioid prescriptions for chronic pain. According to the Associated Press, conflicts of interest at the Interagency Pain Research Coordinating Committee include:

“[Two] panelists work[ing] for the Center for Practical Bioethics, a Kansas City group which receives funding from multiple drugmakers, including OxyContin-maker Purdue Pharma, which donated $100,000 in 2013.

One panelist holds a chair at the center created by a $1.5-million donation from Purdue Pharma. The other has received more than $8,660 in speaking fees, meals, travel accommodations and other payments from pain drugmakers …

A third member of the panel is a director with the U.S. Pain Foundation, a nonprofit that receives most of its funding from drugmakers, including a $104,800 donation from Purdue Pharma in 2014, according to IRS Records cited by Wyden.

Two other panelists are connected to the American Chronic Pain Association, another nonprofit that receives substantial funding from drugmakers, including Pfizer Inc., AstraZeneca Plc, Teva Pharmaceuticals Industries Ltd., and AbbVie Inc.”

In some cases, doctors are motivated significantly by monetary gain. They transform their practices into “pill mills,” writing scripts for opioids for money without any oversight, risking their medical license and facing jail time.

However, we should not place all the blame on physicians. On the one hand, doctors are under a lot of pressure from advocacy groups (some Pharma-backed), government agencies, and patients to treat pain more seriously. On the other hand, doctors face increasing pressure to see and treat patients quickly and efficiently. Stanford addiction specialist Anna Lembke, author of Drug Dealer, MD, states, “There is tremendous pressure on doctors within these large integrated health care centers to practice medicine in a certain way and get patients out in a timely fashion to be able to bill insurers at the highest possible level and to make sure that their patients were satisfied customers.”

The increase in opioid prescribing is fueled by a multifaceted campaign underwritten by pharmaceutical companies. This campaign advertised minimized opioid risks and exaggerated the benefits of using opioids over the long term for chronic pain.

It seemed like a win-win situation with cheap, effective care and people bought into the idea. For example, UnitedHealthcare, the nation’s largest health insurer, places morphine on its lowest-cost drug coverage tier with no prior permission required. Lyrica, a non-opioid, brand-name drug that treats nerve pain, is on its most expensive tier, and patients are required to try other drugs first. Leo Beletsky, an associate professor of Law and Health Sciences at Northeastern University, calls the health insurance system “one of the major causes of the crisis” because doctors are given incentives to use less expensive treatments that provide fast relief.

It seems as if there is a common theme when it comes to this crisis…Money!

As they say “Money makes the world go ‘round” and this is surely the theme when it comes to government involvement in this crisis. Federal officials have been intensely lobbied by a drug company-funded group called IMMPACT whose stated goal is “improving the design, execution, and interpretation of clinical trials of treatments for pain.”

For a fee as high as $35,000, IMMPACT promises to get drug company representatives into invitation-only meetings of government officials and academic leaders, where they can lobby NIH researchers and FDA officials one-on-one. The public and press are not allowed in these meetings, which date back to 2002.

Both Purdue Pharma, the maker of OxyContin, and Janssen, the company which makes the opioids Duragesic and Nucynta, have acknowledged the value of IMMPACT. Also, industry-funded groups such as the Pain Care Forum, spent $740 million over a decade lobbying in Washington and state legislatures against limits on opioid prescribing and similar issues, according to the Center for Public Integrity.

The pharmaceutical industry has about two lobbyists for every member of Congress. They spent $152 million influencing proposed legislation in 2016, according to the Center for Responsive Politics. Drug companies also contributed more than $20 million directly to political campaigns last year. About 60 percent went to Republican campaigns. Paul Ryan, the Speaker of the House of Representatives, was the single most significant beneficiary with donations from the industry totaling $228,670.

Perhaps, the opioid problem could resolve if the leaders of our country looked beyond the lucrative donations from the big pharmaceutical companies and started paying attention to what the effects are on the citizens of this country. Until then its safe to say America, we have an opioid problem.

Disclaimer: The views and opinions expressed here are those of the author and do not necessarily reflect the editorial position of The Globe Post.
Share76Tweet1
Adam Chowdhury

Adam Chowdhury

Health-care MBA student at The George Washington University

Related Posts

Native American Homelessness
National

Homelessness, Drug Use Rife at Native American Tent City

by Staff Writer
October 25, 2018
Next Post
Lu Wei

China's Former Internet Czar Expelled from Communist Party

a hospital in Gaza City

Over 50 Palestinians Died in 2017 Waiting for Medical Permits From Israel

Please login to join discussion

Recommended

People in South Sudan

Conflict-Related Sexual Violence Plagues Regions of South Sudan

February 15, 2019
Women with children in Syria's Rukban camp

Early Marriages, ‘Survival Sex’ Last Resort for Women in Syria’s Rukban

February 15, 2019
US President Donald Trump inspects border wall prototypes

US Judge Rules Against Butterfly Sanctuary Opposed to Trump’s Wall

February 15, 2019
A man at work in U.S. auto-manufacturing plant.

US Manufacturing Plunges Dramatically in January

February 15, 2019
Prime Minister Benjamin Netanyahu attends the weekly cabinet meeting in Jerusalem on November 19, 2017

Israel Leaked Video of Gulf Ministers at Anti-Iran Meet [Reports]

February 15, 2019
Myanmar's Aung San Suu Kyi

Myanmar’s Leading Lady: The Deification of Aung San Suu Kyi

February 15, 2019

Opinion

Myanmar's Aung San Suu Kyi

Myanmar’s Leading Lady: The Deification of Aung San Suu Kyi

February 15, 2019
Rescued Cameroonian migrant Josepha, 40-years-old, rests on board the Spanish NGO Proactiva Open Arms boat as it sails back to Spain in the Mediterranean Sea on July 17, 2018

Migrant Containment at all Costs: What is Left of European Humanity?

February 14, 2019
People scavenging for food in the streets of Venezeula's capital Caracas

Regime Change is Only Way to Save 32 Million Venezuelans from Downright Starvation

February 14, 2019
Rohingya Urgently Need Relief, but is World Willing to Make an Effort?

Rohingya Urgently Need Relief, but is World Willing to Make an Effort?

February 13, 2019
People in traditional dress arrive to vote in the Mongolia's presidential election of 2017

What’s Next for Mongolia’s Troubled Oasis of Democracy?

February 13, 2019
An Armenian man holds a placard reading "Hands off Karabakh" during a rally in Yerevan in 2016

Recent Optimism for Solution in Frozen Conflict Between Armenia and Azerbaijan is Misplaced

February 12, 2019
Facebook Twitter

Newsletter

Do you like our reporting?
SUBSCRIBE

About Us

The Globe Post

The Globe Post is part of Globe Post Media, a U.S. digital news organization that is publishing the world's best targeted news sites.

submit oped

© 2018 The Globe Post

No Result
View All Result
  • National
  • World
  • Business
  • Interviews
  • Lifestyle
  • Democracy at Risk
    • Media Freedom
  • Opinion
    • Editorials
    • Columns
    • Book Reviews
    • Stage
  • Submit Op-ed

© 2018 The Globe Post